Skip to main content
American Journal of Nuclear Medicine and Molecular Imaging logoLink to American Journal of Nuclear Medicine and Molecular Imaging
. 2018 Jun 5;8(3):169–188.

X-ray fluorescence imaging of metals and metalloids in biological systems

Run Zhang 1, Li Li 1, Yasmina Sultanbawa 2, Zhi Ping Xu 1
PMCID: PMC6056246  PMID: 30042869

Abstract

Metals and metalloids play fundamental roles in many physiological processes in biological systems, but imbalance of these elements in the body may cause many diseases, such as Parkinson’s disease, Alzheimer’s disease, and even cancers. Thus, to better understand the metallome in health and disease, quantitative determination of their localization, concentration, speciation, and related metabolism at cellular or subcellular levels is of great importance. X-ray fluorescence (XRF) imaging, as a new generation of analytical technique, has been reported as an ideal tool to quantitatively map multiple metals and metalloids in tissues with reasonable sensitivity, specificity, and resolution. In the current review, we have introduced the general concept of XRF imaging technique, reviewed the recent advances using XRF imaging to investigate toxicology of metals and metalloids in life science, and discussed the roles of metals and metalloids in various diseases, including cancers and neurodegenerative diseases. We believe that future research on revealing the roles of metals and metalloids in biological systems will directly benefit from the important breakthroughs in developing XRF imaging techniques.

Keywords: X-ray fluorescence, metals and metalloids, fluorescence imaging, toxicology, diseases

Introduction

In this review paper, metals and metalloids may mean the metal ions and any available forms, such as metal-oxygen anions and metal ion-ligand coordinates, and sometimes not strictly, mean some non-metals, such as As, P, Cl etc. that XRF is able to detect, for simplicity in description.

Metals and metalloids in biological systems

Metals and metalloids perform critical roles in fundamental processes required for all biological species, including osmotic regulation, catalysis, metabolism, biomineralization, and signalling [1,2]. Most biological organisms do not only contain abundant alkali and alkaline earth metals but also store and transport transition metals and metalloids to provide appropriate levels for metalloproteins or cofactors, and protect themselves against the toxic effects [3-5]. In general, the concentration of transition metals and metalloids, such as zinc (Zn), copper (Cu), manganese (Mn), iron (Fe), nickel (Ni), chromium (Cr), arsenate (As) and cadmium (Cd), is much lower than that of alkali and alkaline earth metals [6]. Nevertheless, metalloproteins and metal cofactors are found almost in all plants, animals, and microorganisms [1,7,8].

In living systems, the normal concentration range for each metal or metalloid is narrow (Table 1) [9], while both deficiency and excess of these elements can cause pathological changes [8,10]. For example, the World Health Organization (WHO) and the Food and Agricultural Administration (FAA) suggest that the population mean intake of Cu should not exceed 10-12 mg per day for adults [11]. The deficiency of Cu in the human body would increase the risk associated with developing coronary heart disease [12-14], while the Menke’s disease, Alzheimer’s disease, Parkinson’s disease, Wilson’s disease, and Occipital Horn Syndrome are implicated with the excessive amount of Cu uptake and excretion [13,15-17]. Since metals and metalloids in living systems are essential, researchers in chemistry, biology, and medicine have been attracted to relate their excess or deficiency in living systems to specific diseases [9,16]. Therefore, understanding of the localization, speciation, and metabolism of these metals and metalloids at molecular level is of great importance.

Table 1.

Average relative abundance of selected elements in earth’s crust and mammalian blood plasma [6,9]

Conc. of Metals Ni Cd Zn As Cu Mn Fe Cr Na K Ca
Crust (ppm) 75 0.2 70 1.5 55 950 5 × 104 100 3 × 104 3 × 104 4 × 104
Blood (µM) 0.04 - 17 - 8-24 0.1 22 0.5 1 × 105 4 × 103 2 × 103

It is well known that the metals and metalloids in biological samples exist in different forms, such as free ions, metalloproteins or cofactors formed through complexation [7-9], and are not homogenously distributed in biological cells and tissues [18]. As a consequence, in-situ spatiotemporal analysis of their formation, concentration and distribution in living systems remains a great challenge [4,5]. Up to now, a variety of methods have been developed and used to quantitatively determine these metals and metalloids in biological samples. Among these approaches, in-situ imaging technique has been reported as one of the most promising methods for the study of metals in living systems due to its capability of high spatial and temporal resolution [1,16,19]. Recently, several imaging techniques have been proposed to visualize the location and determine the concentration level of specific metals in biological samples [16,20-22]. Table 2 illustrates an overview of the most important imaging-based microanalytical techniques. Imaging mass spectrometry (IMS) technology is used to record spatial and temporal resolution of metals and metalloids in biological samples at the cellular and/or subcellular levels [5,23,24]. Another imaging technology that permits the mapping of a specific metal in living specimens with high sensitivity and spatiotemporal resolution involves utilization of fluorescent biosensors [4,16,25,26]. When the intracellular biosensor interaction with specific metals or metalloids, the location and level of these elements will be immediately recorded as the changes in fluorescence output, either through an intensity increase or an energy shift of the emitted light [25,26]. Other imaging techniques, such as magnetic resonance imaging (MRI), positron emission tomography (PET), and single-photon emission computed tomography (SPECT), have also been developed for physiological imaging. Although the resolution of these techniques is only at the organ level, their high sensitivity endows them to be widely used in clinical medicine [16,27-31]. These imaging techniques for mapping the metals and metalloids in living systems have recently been comprehensively reviewed elsewhere [4,5,23-26,32,33]. This review will particularly highlight the recent progresses of X-ray fluorescence imaging technology, a new and very promising one developed very recently.

Table 2.

Comparison of the microanalytical techniques [23-31,33-35]

Analytical technique Detection limit Spatial resolution Analytical depth (mm) Quantification Ref
MS 0.01 mg/g 15-50 mm 200 Semiquantitative [23,24]
Fluorescence pM to nM 2-3 mm (in vivo), 0.2-0.5 mm (in vitro) < 1 cm Quantitative/semiquantitative [25,26]
PET High pM 1-2 mm No limit Semiquantitative [27-29]
SPECT Low nM 15-20 mm No limit Semiquantitative [28,29]
MRI mM to low µM 25-100 mm No limit Semiquantitative [30,31]
XRF 0.1-1 mg/g 0.03-0.2 mm > 100 Quantitative [33-35]

X-Ray fluorescence imaging

XRF is an elemental analysis technique, which relies on recording the characteristic secondary X-rays emitted from specific atoms when the materials are irradiated by a focused X-ray beam [34]. The history of XRF dates back to 1895 when German physicist Wilhelm Conrad Röntgen accidentally discovered X-rays during his study of cathode rays in high-voltage, gaseous discharge tube. Based on Röntgen’s discovery, Henry Moseley in 1913 discovered a mathematical relationship between the atom number (Z) and emitted X-ray wavelength. The technique was quickly realized to quantitative analysis of materials using XRF in 1914-1924. While the X-rays have been employed as a standard elemental analysis since 1950s when the first commercial XRF spectrometer was developed [35]. Since then, XRF has attracted increasing consideration and the relevant technique has been widely used for non-invasive imaging of thick and deep biological specimens with high spatial and temporal resolution [36].

As one of the advanced imaging approaches, X-ray fluorescence (XRF) imaging is a powerful technique for the quantitative mapping of distributions and dynamics of elements and chemical species at the spatial submicrometer resolution within biological samples [16,18,34,37]. The physical principle of the XRF is illustrated in Figure 1. Upon excitation by an X-ray photon, a core-shell electron from the specific atom is ejected as a photoelectron. The formed core-hole is then filled by a neighbouring higher energy orbital electron, which results in emission of an X-ray fluorescence photon. The energy of the emitted photon is equal to the difference in binding energies of the two shells involved in the transition [27,37]. Since the binding energy is varied with the nuclear charge, each element has a unique photon energy, i.e., characteristic fingerprint X-ray fluorescence, which enables the multi-element analysis.

Figure 1.

Figure 1

Basic principle of X-ray fluorescence.

Apart from the conventional XRF microprobe, different variations of XRF imaging techniques, such as synchrotron X-ray fluorescence imaging (SXRFI) [16,27,34,37], X-ray fluorescence computed tomography (XRFCT) [16,27,38], confocal XRF (CXRF) [39,40], and total-reflection X-ray fluorescence imaging (TXRFI) [41] have been reported in recent years. Among these techniques, SXRFI has the highest element sensitivity due to absence of the bremsstrahlung background, while XRFCT can provide three-dimensional elemental composition in a sample [27,34]. Therefore, these two techniques are most widely used for the imaging of metals in biological samples.

In particular, SXRFI is a microanalytical technique for mapping the spatial distribution of elements [18,34,42-45]. Due to the unique fluorescence spectrum of each element, simultaneous multi-element analysis can be achieved using SXRFI with qualitative and quantitative modalities. Compared with the conventional micro-XRF (m-XRF), synchrotron X-ray source-equipped SXRFI shows higher sensitivity with the detection limit estimated between 5.0 × 10-20 and 3.9 × 10-19 mol/mm2 and the spatial resolution improved to 150 nm for the imaging of trace elements [18,46,47]. By virtue of deep penetration of synchrotron X-rays, this technique is highly applicable for mapping the metals in biological samples, such as in whole cells or tissue at single cell and subcellular resolution. A variety of cellular studies utilizing SXRF have been conducted, especially the investigation of distribution and abundance of metals in biological samples.

The apparatus of SXRFI typically consists of X-ray source, undulator, crystal monochromator, focusing optics, motorized sample stage, X-ray fluorescence, and transmission detector (Figure 2) [18,27,34,38,48]. Undulator is used to boast a smaller source size of X-ray and produce a beam with enhanced brightness. To select the band of the incident X-ray beam, a crystal monochromator is equipped. The selected X-ray is then focused on the specimen through a Fresnel zone plate [49]. An energy dispersive detector is applied to record the information of multi-element simultaneously. The orientation of biological samples on the specimen scanning stage is corrected by the help of transmission detector.

Figure 2.

Figure 2

Schematic of an X-ray fluorescence microscope construction.

Due to its capability of 3-D elemental mapping within the sample, XRFCT has attracted increasing attention for imaging metals in biological samples in recently years [50,51]. This technique integrates the CT imaging of X-ray attenuation with typical secondary XRF, and thus the 3-D elemental mapping can be obtained by stacking and combining 2-D XRF imaging. Using XRFCT, the specimen is irradiated by a micro- or nano-focused X-ray beam, and the secondary X-ray is collected with an X-ray dispersive detector to record the energy of each XRF photon [27,34]. The XRF detector is designed to be 90° position to the incident X-ray beam to minimize the elastic and Compton scattered photons and improve the signal-to-background ratio [27,52,53]. The conventional XRFI apparatus (Figure 2) with an additional rotation stage is used as the microscope for the XRFCT [54].

The rotation of the XRFCT microscope is illustrated in Figure 3. For the sample with low elemental abundance, the scanning and rotation of the sample along a series of angles is often used [50,55,56]. The focused X-ray beam is raster scanned through the sample, and the XRF intensity is recorded by the XRF detector at each orientation [27]. Typically, the measurement of a single slice of the sample requires several hours, which limits its application in live biological samples. Fortunately, thanks for the improvement of XRF detectors and fast detector electronics, “on-the-fly” sample scanning modality can reduce the X-ray irradiation time, and the live sample 3-D XRFCT is possible [55,57]. In the case of high elemental abundance (circa > 1 wt%), full-field mode of XRFCT with a wide-fan X-ray beam can be used for the specific elemental mapping. With the wide-fan X-ray beam, only several minutes is required to map the metals in biological samples [34,58]. Thus, a large dimension of the sample can be imaged using such a technique with low risk of radiation damage.

Figure 3.

Figure 3

Schematic of a typical XRFCT rotation stage. The XRF is collected by a XRF detector, and X-ray attenuation is recorded by a transmission detector.

XRFCT is a non-invasive and highly sensitive technique for imaging metals with the 3-D model in living samples. In the XRFCT measurement, the pre-treatment of the biological samples, such as staining, fixation, and washing, is not required, which allows the accurate detection of metals in its native condition. The mapping of elemental abundance in living samples can be in the range of submicrogram per gram with a high spatial resolution (hundreds of nanometers) [59]. In addition, similar to the SXRFI, simultaneous multi-element analysis with qualitative and quantitative mode is also possible for XRFCT [27,34].

Considering the essential roles of metals and metalloids in living systems and the unique advances of X-ray fluorescence imaging, we will highlight the recent progresses in this review on using XRF imaging technique to examine metals and metalloids in biological systems. We will focus on the application of XRF imaging in the investigation of toxicology and roles of metals and metalloids, in particular in various diseases at the organ and tissue level, and at cellular or even subcellular level. In addition, the current and future challenges in this field in terms of X-ray fluorescence development and applications are also discussed.

XRF imaging of toxic elements

It has been reported that some of the heavy metals and metalloids, especially Cr, Co, Pb, Hg, As, are highly toxic to human health and the environment. In biological systems, these elements have been reported to affect cellular organelles and components, such as cell membrane, mitochondrion, lysosome, endoplasmic reticulum, nuclei, and some enzymes involved in metabolism, detoxification, and repair of damages [60]. The relative toxicities, symptoms, and the corresponding treatment are listed in Table 3 [61,62]. It has been demonstrated that the mechanisms of toxicity and carcinogenicity of metals and metalloids are relevant to the reactive oxygen species (ROS) production and oxidative stress. Here, we will briefly summarize the progresses of XRF imaging for the most commonly encountered toxic metalloids and metals, including As, Cr, Co, Pb, and Hg in living systems.

Table 3.

Typical toxicities of the most encountered metals and metalloids, and their treatment

Metal Acute Chronic Toxic concentration Treatment
As Nausea, vomiting, “rice-water” diarrhea, encephalopathy, multi-organ dysfunction syndrome, long QT syndrome, painful neuropathy Diabetes, hypopigmentation/hyperkeratosis, cancer: lung, bladder, skin, encephalopathy 24 h urine: ≥50 µg/L urine, or 100 µg/g creatinine BAL (acute, symptomatic)
Succimer
DMPS (Europe)
Cr GI hemorrhage, hemolysis, acute renal failure (Cr6+ ingestion) Pulmonary fibrosis, lung cancer (inhalation) No clear reference standard N-cetylcysteine (experimental)
Co Beer drinker’s (dilated) cardiomyopathy Pneumoconiosis (inhaled); goiter Normal excretion: 0.1-1.2 µg/L (serum) 0.1-2.2 µg/L (urine) NAC
CaNa2 EDTA
Hg Elemental (inhaled): fever, vomiting, diarrhea, acute lung injury; Inorganic salts (ingestion): caustic gastroenteritis Nausea, metallic taste, gingivostomatitis, tremor, neurasthenia, nephrotic syndrome; hypersensitivity (Pink disease) Background exposure “normal” limits: 10 µg/L (whole blood); 20 µg/L (24-h urine) BAL
Succimer
2,3-dimercapto-1-propane-sulfonic acid
Pb Nausea, vomiting, encephalopathy (headache, seizures, ataxia, obtundation) Encephalopathy, anemia, abdominal pain, nephropathy, foot-drop/wrist-drop Pediatric: symptoms or [Pb] ≥45 µ/dL (blood); Adult: symptoms or [Pb] ≥70 µg/dL BAL
CaNa2 EDTA
Succimer

As imaging

Arsenic (As) is widely distributed in the earth via both natural and anthropogenic pathways [63]. Despite its reputation as a deadly poison, As may be a necessary ultratrace element for some biological systems, such as red algae, chickens, rats, goats, and pigs. Excessive arsenic exposure has been associated with increased incidence of cancers, including lung cancers, skin cancers, and urinary bladder carcinoma in humans [64]. Compared to the reports on heavy metals, limited XRF imaging has been conducted to determine the quantitative spatial distribution of As in live cells and tissues, insects, and vertebrate samples such as fur and feathers.

XRF imaging has been applied to visualize the As distribution in HepG2 human hepatoma cells after exposure to arsenite (1 mM) or arsenate (20 mM). Munro et al. found that As was accumulated in the euchromatin region of the cell nucleus (following arsenite exposure), in accordance with As targeting DNA or proteins involved in DNA transcription [65]. The distribution, toxicity and biotransformation of arsenate in different life stages (larvae, pupae and adults) of a bertha armyworm moth (Mamestra configurata Walker) (Lepidoptera: Noctuidae) were investigated by Andrahennadi et al., and XRF imaging revealed the localized arsenic species, as well as zinc and copper within the gut [66].

Arsenic accumulation induced by chronic intake of arsenic-contaminated water has been examined in rat brain using the XRF imaging. The data showed that the accumulation of As was not linearly proportional to the treated arsenic dose, suggesting the existence of a protection mechanism that limits the transport of inorganic arsenic to the brain. The uniform spatial distribution of As was found, which is probably caused by the homogenous blood spreading to the brain [67]. The spatial distribution of As (and Se) has been evaluated at the cellular and subcellular levels in the skin of mice (Figure 4) [68]. Interestingly, the supplemental Se was found being effective preventing As accumulation in skin, suggesting the As-blocking effect of Se.

Figure 4.

Figure 4

Micro-XRF element mapping of hyperplastic epidermis taken from the skin of a mouse exposed to ultraviolet radiation (UVR) and As (III) for 182 days. These images pointed out the differing subcellular distributions of As and Se in mice given As (III) only, particularly in the overlay, where As was clearly evident throughout the nucleus (excluding the nucleus), whereas Se was concentrated in the peripheral region of the cells. Scale bar 100 mm. Adapted from Environmental Health Perspectives, reference [68].

XRF imaging has also been applied to study the toxicity of As in vertebrate samples, such as fur and feathers. For example, using XRF elemental mapping of the hair, Kempson revealed that the cause-of-death of Phar Lap, a successful and famous racehorse, could be As poison [69].

Hg imaging

Hg is a unique heavy metal that exists in three types of chemical species: elemental Hg, inorganic Hg, and organic Hg [63]. The Hg compounds are well known as the most toxic species [70]. Despite their extreme toxicity, humans and animals are all unable to avoid exposure to some forms of Hg because some Hg compounds are ubiquitous in the environment. However, it remains difficult to investigate the Hg uptake mechanism and the interactions with biological species [71]. XRF has been recently reported to visualize the uptake and distribution of Hg in living systems, such as larval stage zebrafish, human brain tissue, teeth, and human bones.

Using synchrotron X-ray fluorescence mapping, Korbas et al. examined the uptake and localization of organic Hg in zebrafish larvae [72]. They found that methyl and ethyl Hg compounds were mainly accumulated in the rapidly dividing lens epithelium, with lower levels in the brain, optic nerve and various other organs, implying the direct effects of Hg on the ocular tissue. The detailed mechanism underlying organic Hg transport and accumulation has been then investigated [73]. As shown in Figure 5, redistribution of Hg to the eye lens was observed after removal of fish from treatment solutions (contaminated with methyl-Hg L-cysteineate), indicating that eye lens are the major sink for methyl-Hg in early embryonic and larval stages.

Figure 5.

Figure 5

Histological images (lower) of head and XRF imaging (upper) quantitative Hg distributions in zebrafish larvae after a 12-h exposure to 2 µM methyl-Hg L-cysteineate (t = 0) followed by recovery time t = 24 h or 60 h in fresh system water. Scale bar 100 mm, BR: brain, EL: eye lens. Scale bar 100 mm. Adapted from JBIC Journal of Biological Inorganic Chemistry reference [73] with permission.

Inorganic Hg uptake and distribution were also investigated by Korbas et al. [74]. Unlike the methyl-Hg species [75], inorganic Hg was highly concentrated in olfactory epithelium and kidney in the absence of L-cysteine. However, with L-cysteine present in the treatment solution, mercuric bis-L-cysteineate species dominated the treatment, significantly decreasing uptake. In addition, quantitative XRF imaging was used to analyze Hg uptake in the absence and presence of 1-phenyl-2-thiourea (PTU), a widely used inhibitor to generate essentially transparent organisms for larval zebrafish [76]. The Hg concentration in the fish treated with solution of PTU + HgCl2 was 60-fold lower than that in fish exposed to HgCl2 solution. In contrast, both head and trunk sections of the larvae treated with CH3HgCl and PTU had two fold higher Hg than in those treated with CH3HgCl alone.

XRF imaging has also been employed to study the co-localization of Hg in biological samples [77]. When the human brain tissues were poisoned by methyl-Hg, Hg and Se were co-localized in the grey matter in the form of HgSe nanoparticle [78]. Exposure of larval zebrafish to inorganic Hg also showed nano-scale structures containing co-localized Hg and Se [79]. Supported by the microscaled X-ray absorption analysis, the co-localized deposits were most likely comprised of highly insoluble mixed chalcogenide HgSxSe(1-x) where x was 0.4-0.9, probably with the cubic zincblende structure.

Spatial distribution of Hg in human teeth filled with amalgams for more than 20 years has been determined by XRF imaging analysis [80]. Up to ~10 mg/g Hg was detected in the dentinal tubules several millimetres away from the amalgam location. In addition to Hg in human teeth, XRF imaging has been also employed to determine whether Hg is present in the bone as a result of environmental contamination or due to biogenic uptake [81]. The results revealed that Hg existed in part of the localized subset of the osteons.

Pb imaging

Pb is a toxic heavy metal that is taken up by the human body through food, drinking water, and inhalation, and is excreted via the gastrointestinal tract and the renal system [63]. Exposure to Pb is associated with chronic diseases in the nervous, hematopoietic, skeletal, renal and endocrine systems. It is known that Pb accumulates in the skeleton [82]. Thus, the understanding of Pb toxicity is of great importance due to the lack of treatment options for Pb-induced diseases.

XRF imaging could make a significant contribution, although to date only a few XRF imaging studies have been reported about Pb in animal systems. In 2006, Zoeger et al. used high resolution XRF imaging to determine the spatial distribution of Pb and other trace elements in normal articular cartilage and subchondral bone from adult humans with no history of work-related exposure to Pb [83]. As shown in Figure 6, a highly specific accumulation of Pb occurred in the tidemark, the transition zone between calcified and non-calcified articular cartilage. Quantitative fluorescence analysis revealed that a 13-fold higher Pb concentration was in the tidemark of articular cartilage when compared to subchondral bone [83]. The observation was further confirmed by the same research team through investigation of the osteochondral samples, which were long-term treated to increased lead (Pb) concentrations [84,85].

Figure 6.

Figure 6

A. Backscattered electron (BE) image of analyzed chondral/subchondral region of the patella. Non-calcified cartilage (I), tidemark (II), calcified cartilage (III), subchondral bone (IV), and cement-lines (V) can be clearly identified. Length of scale bar: 100 mm. B. Ca, Zn, Sr, Pb signal intensity mapping in the corresponding region. C. Fluorescence intensity profiles along the marked line. Maximum fluorescence intensities were normalized to 10. Pb and Zn maxima can be exactly allocated to the tidemark of articular cartilage. Scale bar 100 mm. Adapted from Osteoarthritis and Cartilage reference [83] with permission.

The distribution of Pb in the human bone tissue has been also determined by XRF imaging [86-88]. The studies conducted by Zoeger et al. revealed that Pb was mostly located at the outer border of the cortical bone in various samples [87]. A remarkable association between Pb and Zn content can also be observed. Pemmer et al. reported that the levels of Pb and Zn were significantly higher in the cement lines than the adjacent mineralized bone matrix, possibly due to the different uptake mechanism [86]. Arora et al. reported the first application of XRF imaging technique in measuring the distribution of Zn and Pb in the ameloblasts in developing Wistar rat teeth. Results showed that Pb was only visualized reliably in developing enamel but not in ameloblasts [89]. Interestingly, XRF imaging has been reported as a useful technology in archaeological studies, and used to analyze bone and hair samples from Ferrante II of Aragon, King of Naples (1469-1496) and Isabella of Aragon, Duchess of Milan (1470-1524). Results showed that Pb was localized to microanatomical locations, consistent with bone remodelling events and compositionally similar to Pb-substituted hydroxyapatite, i.e. Pb binding in bone [90].

Co imaging

Co is very much widespread in the natural environment [91]. For humans, Co is an essential trace element required for the generation of vitamin B12. However, it becomes toxic at high concentrations, thus leading to adverse health effects [16]. There are a few studies done to investigate Co toxicity, uptake, transport, and distribution using XRF imaging analysis [92,93].

In 2009, XRF imaging analysis in tomography mode was performed for the first time on a single cell (HaCaT human keratinocytes) to determine the 3D intracellular distribution of cobalt [93]. The images showed that Co was distributed in the nucleus and perinuclear region in HaCaT cells, implying the possible direct interactions with genomic DNA and nuclear proteins. The perinuclear accumulation in the cytosol suggests that cobalt could be stored in the endoplasmic reticulum or the Golgi apparatus. In addition, when the cells were exposed to exogenous Co, a decreasing level of Zn and Mg was found, indicating a likely replacement Mg and Zn by Co in protein binding sites.

Cr imaging

Cr plays important roles in biological functions of life, but can become toxic at higher doses. Its toxicity is also dependent on its chemical state [63]. It is well known that Cr compounds are stable in both trivalent [Cr(III)] and hexavalent [Cr(VI)] state. Exposure of human beings and animals to Cr has been a major concern because of the high risk of Cr-induced cancers, such as lung cancer [94]. A generally accepted mechanism for Cr(VI)-induced genotoxicity and cancers includes intracellular internalization (through anion channels for water-soluble chromates or phagocytosis of insoluble chromates), transport, reduction to Cr(III), and then formation of Cr-DNA and Cr-protein complexes.

The mechanism of Cr toxicity in live systems can be directly examined by XRF imaging [95]. The investigation conducted by Fayard et al. showed homogenous distribution of Cr in Chinese Hamster Ovary cells (CHO-AA8) exposed in vitro to both soluble and insoluble Cr compounds. Interestingly, Cr(VI) was not detected, suggesting a mechanism of rapid intracellular reduction [96]. Further studies in the same group confirmed the reduction of Cr(VI) to Cr(III) and revealed the distribution in nucleus of Institut Gustave Roussy ovarian cell line 1 (IGR-OV1) cells [97]. Cr seemed to accumulate P-rich regions, such as nucleus and the area outside the nucleus (acidic vacuole), as reported by Dillon et al. in V79 Chinese hamster lung cells. This accumulation may indicate that Cr is capable of targeting the DNA and causing the genotoxic damage [98].

Using XRF imaging, Harris et al. investigated the dynamic process of intracellular uptake, distribution, and biotransformation of Cr(VI) in human lung cells [99]. A549 human lung adenocarcinoma epithelial cells were treated with Cr(VI) at 100 mM for 20 min and 4 h, respectively. As shown in Figure 7, Cr was found in a small area of cytoplasm after 20 min treatment, while distributed to whole cells after 4 h treatment due to uptake of more Cr. Interestingly, a higher Cr concentration in the nucleus and cytoplasmic membrane was still observed, indicating the accumulation in the nucleus and the cytosol [97].

Figure 7.

Figure 7

Distribution mapping (A) and relative amount (B) taken up by single A549 human lung carcinoma cell treated with 100 µM Cr(VI) in comparison with untreated cells. Adapted from JBIC Journal of Biological Inorganic Chemistry reference [99] with permission.

XRF imaging of metals for various diseases

Imaging of metals in cancer research

The association of metal exposure with cancers is well documented [100]. Currently, metals are thought to promote cancer development by a number of mechanisms, such as inducing reactive oxygen species (ROS) to oxidatively damage DNA, protein, and lipids [101,102]. Thus, XRF imaging technique has been actively used to study the relationship between the metal concentrations and a number of cancers, including breast cancer, prostate cancer, and colorectal cancer recently [56,103-105].

XRF has been applied to image K, Fe, Cu, Zn, and Ca in breast cancer [106-108]. Compared to that in the normal tissues, the concentration of assessed metals increased in the tumour region, especially Zn and Cu [106,109,110]. Further investigation by Farquharson et al. confirmed the increasing concentration of Ca, Cu, and Zn in the tumour lesion, but a lower concentration of Fe in some of the tested samples [109,111]. Zn is being considered as a possible marker of human prostate cancer [112]. Using XRF imaging, Ide-Ektessabi reported that the Zn concentration is significantly lower in prostate cancer tissues compared with that in health specimens [113]. This finding was further confirmed by Podgórczyk et al. [112]. The correlation between Zn and Ca suggested that Ca mediated Zn accumulation in prostate cancer tissues [114].

Metals in other cancer lesions and organs have been also investigated using XRF imaging technology. The localization and the relative concentration of Zn, Cu, Fe and Ca in primary colorectal cancer and secondary colorectal liver metastases were examined by Al-Ebraheem et al. Significant increase in the concentration of Zn, Ca, Cu and Fe was found in necrotic tissues [115]. They also quantified the concentration of Fe, Cu, Zn, and K in normal and malignant liver and kidney tissues. The data indicated that the Zn concentration was reduced by 63% and 26% in liver and kidney tumors, respectively. Fe, Cu, and K concentrations were increased in kidney tumors by 150%, 8% and 90%, but reduced in liver tumors by 76%, 29% and 43%, respectively [116].

Among all metals investigated in cancer research, Cu is special due to its special roles in cancer development [111]. It is well known that angiogenesis is vital for supplying oxygen for the tumor growth. Thus, depletion of Cu has been shown to inhibit angiogenesis in a wide variety of cancer cells and xenograft systems [117]. Using XRF imaging, Finney et al. investigated the localization and roles of Cu in angiogenesis system. They found that Cu was remarkably redistributed from intracellular compartments to the tips of nascent endothelial cell filopodia and across the cell membrane [118].

Imaging of metals for neurodegenerative diseases

The brain is rich in metals, such as Fe, Cu, and Zn as essential cofactors in metalloproteins, and Hg and Pb as neurotoxins [119,120]. These metals have been implicated in various neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis (ALS), prion diseases, and Huntington’s disease [121]. There is increasing investigation of precise roles of these metals in neurodegenerative diseases using XRF imaging technology [122].

Utilizing XRF imaging, Pushie et al. investigated the level and distribution of Cu, Fe and Zn in the brain of mice that express different levels of prion protein (PrPC), a family of fatal neurodegenerate diseases [123]. Results suggested that the amount and distribution of specific metals within the central nervous system is regulated by the PrPC. Subcellular distribution of metals in a childhood neurodegenerative disorder revealed that Zn nuclear-to-cytoplasmic trafficking was perturbed in diseased cells and the Ca subcellular distribution was drastically altered in CbCln6 nclf cells [124].

Mn is well known as the magnetic resonance imaging (MRI) reagent in vivo. However, it is reported that Mn is neurotoxic, by accumulating in the hippocampal formation (HPCf) of brain and causing symptoms similar to those associated with Parkinson’s disease [125,126]. Thus, Robison et al. examined the distribution of Mn in the HPCf for Sprague-Dawley rats with chronic Mn exposure, and quantitatively compared Mn distribution with that of other biologically relevant metals, such as Fe, Cu and Zn [127]. In consistence with MRI results, an increasing Mn concentration in hippocampal, especially in the dentate gyrus (DG) and the cornus ammonis 3 (CA3) layer, was observed. In addition, significant spatial correlation of Mn-Zn was observed across the HPCf substructures (Figure 8).

Figure 8.

Figure 8

Analysis of the hippocampal formation regions. A. Two colored images displaying Fe-Mn, Cu-Mn, and Zn-Mn respectively. Note that Mn and Zn co-localized in the CA3 of the HPCf, while a small portion of Mn also co-localized with Fe within the DG as indicated by white pixels in the images. Scale bar: 1 mm. B. Scatter plots of the mean metal concentrations in regions identified by clustering. Scale bar 1 mm. Reproduced from reference [127] with permission of The Royal Society of Chemistry.

XRF imaging was also used to investigate the roles of metals associated with stroke [128] and epilepsy [129-132]. Images showed that Cu plays important roles in the pathogenesis of epilepsy in the Wistar rats. Lower levels of Cu were found in the latent period compared with the control group and even in the acute period [131]. In quantitative analysis of rat brain undergoing pilocarpine-induced epilepsy, a relatively lower Cu level was found in the dentate gyrus, and a lower Zn level in the hippocampus and dentate gyrus, where a higher Ca level was observed in this area [132].

Alzheimer’s disease (AD) is the leading cause of dementia in the elderly, affecting more than 27 million people worldwide (about 2% population in the developed world [133-135]. It is one of the most prevalent and debilitating neurodegenerative diseases and yet it is typically diagnosed only after cognitive symptoms appear, which is normally too late for effective treatment [134]. Pathologically, AD is characterized by extracellular amyloid plaques composed of insoluble amyloid beta (Aβ) protein, and intra-neuronal neurofibrillary tangles (NFTs) containing hyperphosphorylated tau protein. At the molecular level, metals, including Cu, Zn and Fe, have been confirmed as neurochemical factors to be involved in the metabolism and functional expression of Aβ and amyloid precursor protein (APP) [135].

XRF imaging has been developed for the quantitative analysis of metal metabolism in animal models (Figure 9) [136]. The observations reported by Leskovjan et al. revealed that the level of Zn, Cu, Ca, and Fe was all increased in human amyloid plaques, suggesting that these metals are involved in neurodegeneration [137]. Further studies on the time course of the metal concentration and distribution by the same group revealed that Fe in the cortex was 34% higher than age-matched controls at an early stage, corresponding to the commencement of plaque formation [138]. Using XRF imaging, Wang et al. found that Fe and Ca level increased with brain aging in both AD and control mice, while the level of Cu, Fe, Zn and Ca appeared significantly high in AD mice and showed an obvious age-dependent rise [139]. The increase of Zn in a small regional hippocampal was also confirmed by Adlard et al. via XRF imaging [140].

Figure 9.

Figure 9

The quantitative images of Ca, Fe, Cu and Zn in the brain section of Alzheimer’s disease mouse. a: Substantia nigra region, b: Superior colliculus, c: CA3 area of hippocampus, d: Dentate gyrus region. Scale bar 1 mm. Adapted from reference [136] with permission of The Royal Society of Chemistry.

Parkinson’s disease (PD) is a progressive neurological condition [141]. PD is the most common serious movement disorder in the world, and affects about 1% adults older than 60 years and 4% populations older than 80 years. The most characteristic hallmark of PD is confirmed to be the loss of dopaminergic (DA) neurons within the substantia nigra pars compacta (SNc). Nevertheless, the triggers for these events are still unclear [142,143], while the changes in biometals in brain have long been suspected to play a key role in the PD development. Recently, XRF imaging has been evaluated by mapping and quantifying metals, such as Fe, Zn ad Cu in brain slices from PD and unaffected brains [144,145].

Employing XRF imaging of trace elements in the pathogenesis of PD, Chwiej et al. demonstrated that elements P, Cl, Fe, Cu and Zn played important roles in the process of differentiation between neurons [145]. Due to the importance of Cu, Davies et al. investigated the changes in Cu and Cu-associated pathways in the vulnerable substantia nigra (SN) and locus coeruleus (LC) and non-degenerative brain regions. They found a significant decreasing in levels of Cu and Cu-transporter protein 1 in surviving neurons in the SN and LC in PD patients [146].

Robison et al. introduced XRF imaging as a new quantitative tool to determine the Mn distribution in the brain [147]. As shown in Figure 10, the highest Mn level was observed in the globus pallidus (GP), the thalamus (Th), and the substantia nigra pars compacta (SNc) in the brain. But following studies showed that Mn accumulation in SNc is higher than GP and Th. [126]. Dučić et al. showed that Mn was localized in cytoplasmic/paranuclear in dopaminergic neurons after treated with Mn [148], while Mn was accumulated within Golgi apparatus in dopaminergic cells, PC-12 [149].

Figure 10.

Figure 10

XRF imaging of Mn distribution in brain sections of control and treated rats. Mn distribution of coronal sections from untreated (control) rats (A) and Mn treated rats (B). AB, axonal bundle; CPu, caudate putamen; GP, globus pallidus; HPC, hippocampal formation; IC, internal capsule; lv, lateral ventricle; Th, thalamus; SNc, substantia nigra compacta; SNr, substantia nigra reticular. Scale bar 2 mm. Adapted from PLOS ONE, reference [147].

Conclusions and future perspectives

Over the past decade, XRF imaging technique for determining the level and distribution of metals and metalloids has been rapidly developed. This method has been recognized as an ideal tool to reliably determine the elemental distribution in tissue specimens at the cellular, even subcellular level with high sensitivity and low background. In this review, we have presented the general principle of XRF imaging and summarized the recent applications in determining the spatial distribution of metals and metalloids in biological specimens to examine their toxicology and their possible roles in development of various diseases. After a thorough survey of published papers, we are sure that XRF imaging will become a superior tool to study metals and metalloids in animals and humans in the near future.

However, this new technique has faced a few challenges in the future applications in life science. The first challenge is the imaging scan speed bottleneck. At current, the scan speed is relatively slow, so XRF imaging is still not suitable for high-throughput analysis. The second challenge is the limited imaging resolution. It is true that imaging of metals and metalloids has been reported at the cellular or even subcellular levels, higher resolution is still required to determine the distribution and understand the biomolecule-metal interactions as well as metal metabolism, which may help reveal the detail mechanisms that metals or metalloids are involved in disease development. Thus, faster and more efficient imaging system with higher resolution will be an important research direction. The third challenge is the imaging sensitivity limitation. As summarized in this review, current applications of XRF imaging are mainly focused on the toxicology of metals and metalloids, and their possible physiopathology in cancers and neurodegenerative diseases. As a powerful imaging technology, XRF should be widely used to map the trace amount of elements in other diseases, such as cardiovascular diseases [150,151], atheroscelerosis [152], and dental diseases [153,154], improving our understanding of the roles that metals and metalloids play in the development of these diseases.

Acknowledgements

The authors acknowledged the financial support by Australian Research Council (ARC) Discovery Project (DP170104643) and DECRA Fellowship (DE170100092).

Disclosure of conflict of interest

None.

References

  • 1.Domaille DW, Que EL, Chang CJ. Synthetic fluorescent sensors for studying the cell biology of metals. Nat Chem Biol. 2008;4:168–175. doi: 10.1038/nchembio.69. [DOI] [PubMed] [Google Scholar]
  • 2.Metals in chemical biology. Nat Chem Biol. 2008;4:143–143. doi: 10.1038/nchembio0308-143. [DOI] [PubMed] [Google Scholar]
  • 3.Zecca L, Youdim MB, Riederer P, Connor JR, Crichton RR. Iron, brain ageing and neurodegenerative disorders. Nat Rev Neurosci. 2004;5:863–873. doi: 10.1038/nrn1537. [DOI] [PubMed] [Google Scholar]
  • 4.Qian X, Xu Z. Fluorescence imaging of metal ions implicated in diseases. Chem Soc Rev. 2015;44:4487–4493. doi: 10.1039/c4cs00292j. [DOI] [PubMed] [Google Scholar]
  • 5.Susnea I, Weiskirchen R. Trace metal imaging in diagnostic of hepatic metal disease. Mass Spectrom Rev. 2016;35:666–686. doi: 10.1002/mas.21454. [DOI] [PubMed] [Google Scholar]
  • 6.Wasowicz W, Gromadzinska J, Rydzynski K, Tomczak J. Selenium status of low-selenium area residents: polish experience. Toxicol Lett. 2003;137:95–101. doi: 10.1016/s0378-4274(02)00383-1. [DOI] [PubMed] [Google Scholar]
  • 7.Andrews NC. Metal transporters and disease. Cur Opin Chem Biol. 2002;6:181–186. doi: 10.1016/s1367-5931(02)00307-1. [DOI] [PubMed] [Google Scholar]
  • 8.Sigel A, Sigel H. Metal ions in biological systems, volume 35: iron transport and storage microorganisms, plants, and animals. Metal-Based Drugs. 1998;5:262. doi: 10.1155/MBD.1998.262a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Laurie SH. Transport and storage of metals. J Inherit Metab Dis. 1983;6:9–14. doi: 10.1007/BF01811317. [DOI] [PubMed] [Google Scholar]
  • 10.Williams RJ. Role of transition metal ions in biological processes. Royal Inst Chem Rev. 1968;1:13–38. [Google Scholar]
  • 11.Uauy R, Maass A, Araya M. Estimating risk from copper excess in human populations. Am J Clin Nutr. 2008;88:867S–871S. doi: 10.1093/ajcn/88.3.867S. [DOI] [PubMed] [Google Scholar]
  • 12.Meng Q, Shi Y, Wang C, Jia H, Gao X, Zhang R, Wang Y, Zhang Z. NBD-based fluorescent chemosensor for the selective quantification of copper and sulfide in an aqueous solution and living cells. Org Biomol Chem. 2015;13:2918–2926. doi: 10.1039/c4ob02178a. [DOI] [PubMed] [Google Scholar]
  • 13.Maity D, Manna AK, Karthigeyan D, Kundu TK, Pati SK, Govindaraju T. Visible-near-infrared and fluorescent copper sensors based on julolidine conjugates: selective detection and fluorescence imaging in living cells. Chem Eur J. 2011;17:11152–11161. doi: 10.1002/chem.201101906. [DOI] [PubMed] [Google Scholar]
  • 14.Zhang R, Yu X, Yin Y, Ye Z, Wang G, Yuan J. Development of a heterobimetallic Ru(II)-Cu(II) complex for highly selective and sensitive luminescence sensing of sulfide anions. Anal Chim Acta. 2011;691:83–88. doi: 10.1016/j.aca.2011.02.051. [DOI] [PubMed] [Google Scholar]
  • 15.Maity D, Govindaraju T. Highly selective visible and near-IR sensing of Cu2+ based on thiourea-salicylaldehyde coordination in aqueous media. Chem Eur J. 2011;17:1410–1414. doi: 10.1002/chem.201002570. [DOI] [PubMed] [Google Scholar]
  • 16.McRae R, Bagchi P, Sumalekshmy S, Fahrni CJ. In situ imaging of metals in cells and tissues. Chem Rev. 2009;109:4780–4827. doi: 10.1021/cr900223a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Meng Q, Zhang R, Jia H, Gao X, Wang C, Shi Y, Everest-Dass AV, Zhang Z. A reversible fluorescence chemosensor for sequentially quantitative monitoring copper and sulfide in living cells. Talanta. 2015;143:294–301. doi: 10.1016/j.talanta.2015.04.072. [DOI] [PubMed] [Google Scholar]
  • 18.Qin Z, Caruso JA, Lai B, Matusch A, Becker JS. Trace metal imaging with high spatial resolution: applications in biomedicine. Metallomics. 2011;3:28–37. doi: 10.1039/c0mt00048e. [DOI] [PubMed] [Google Scholar]
  • 19.Huang X, Lee S, Chen X. Design of “smart” probes for optical imaging of apoptosis. Am J Nucl Med Mol Imaging. 2011;1:3–17. [PMC free article] [PubMed] [Google Scholar]
  • 20.Carter KP, Young AM, Palmer AE. Fluorescent sensors for measuring metal ions in living systems. Chem Rev. 2014;114:4564–4601. doi: 10.1021/cr400546e. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Dean KM, Qin Y, Palmer AE. Visualizing metal ions in cells: an overview of analytical techniques, approaches, and probes. BBA-Mol Cell Res. 2012;1823:1406–1415. doi: 10.1016/j.bbamcr.2012.04.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Aragay G, Pons J, Merkoçi A. Recent trends in Macro-, Micro-, and nanomaterial-based tools and strategies for heavy-metal detection. Chem Rev. 2011;111:3433–3458. doi: 10.1021/cr100383r. [DOI] [PubMed] [Google Scholar]
  • 23.Becker JS, Matusch A, Becker JS, Wu B, Palm C, Becker AJ, Salber D. Mass spectrometric imaging (MSI) of metals using advanced brainmet techniques for biomedical research. Int J Mass Spectrom. 2011;307:3–15. [Google Scholar]
  • 24.Schwartz S, Caprioli R. Imaging mass spectrometry: viewing the future. In: Rubakhin SS, Sweedler JV, editors. Mass spectrometry imaging. Humana Press; 2010. pp. 3–19. [DOI] [PubMed] [Google Scholar]
  • 25.Yeung MC, Yam VW. Luminescent cation sensors: from host-guest chemistry, supramolecular chemistry to reaction-based mechanisms. Chem Soc Rev. 2015;44:4192–4202. doi: 10.1039/c4cs00391h. [DOI] [PubMed] [Google Scholar]
  • 26.Pal S, Chatterjee N, Bharadwaj PK. Selectively sensing first-row transition metal ions through fluorescence enhancement. RSC Adv. 2014;4:26585–26620. [Google Scholar]
  • 27.Chen H, Rogalski MM, Anker JN. Advances in functional X-ray imaging techniques and contrast agents. Phys Chem Chem Phys. 2012;14:13469–13486. doi: 10.1039/c2cp41858d. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Beekman FJ, van der Have F, Vastenhouw B, van der Linden AJA, van Rijk PP, Burbach JP, Smidt MP. U-SPECT-I: a novel system for submillimeter-resolution tomography with radiolabeled molecules in mice. J Nucl Med. 2005;46:1194–1200. [PubMed] [Google Scholar]
  • 29.Rahmim A, Zaidi H. PET versus SPECT: strengths, limitations and challenges. Nucl Med Commun. 2008;29:193–207. doi: 10.1097/MNM.0b013e3282f3a515. [DOI] [PubMed] [Google Scholar]
  • 30.Wang Y, Song R, Guo K, Meng Q, Zhang R, Kong X, Zhang Z. A gadolinium(iii) complex based dual-modal probe for MRI and fluorescence sensing of fluoride ions in aqueous medium and in vivo. Dalton Trans. 2016;45:17616–17623. doi: 10.1039/c6dt02229d. [DOI] [PubMed] [Google Scholar]
  • 31.Cheon J, Lee JH. Synergistically integrated nanoparticles as multimodal probes for nanobiotechnology. Acc Chem Res. 2008;41:1630–1640. doi: 10.1021/ar800045c. [DOI] [PubMed] [Google Scholar]
  • 32.Kaur K, Saini R, Kumar A, Luxami V, Kaur N, Singh P, Kumar S. Chemodosimeters: an approach for detection and estimation of biologically and medically relevant metal ions, anions and thiols. Coord Chem Rev. 2012;256:1992–2028. [Google Scholar]
  • 33.Formica M, Fusi V, Giorgi L, Micheloni M. New fluorescent chemosensors for metal ions in solution. Coordination Chem Rev. 2012;256:170–192. [Google Scholar]
  • 34.Pushie MJ, Pickering IJ, Korbas M, Hackett MJ, George GN. Elemental and chemically specific X-ray fluorescence imaging of biological systems. Chem Rev. 2014;114:8499–8541. doi: 10.1021/cr4007297. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Taylor M, Bytheway R, Tanner BK, Watanabe M, Isoyama G, Spielmann C. X-Ray spectrometry: recent technological advances. John Wiley & Sons, Ltd; 2004. X-Ray sources; pp. 13–62. [Google Scholar]
  • 36.West M, Ellis AT, Potts PJ, Streli C, Vanhoof C, Wegrzynek D, Wobrauschek P. Atomic spectrometry update-X-ray fluorescence spectrometry. J Anal At Spectrom. 2011;26:1919–1963. [Google Scholar]
  • 37.Fahrni CJ. Biological applications of X-ray fluorescence microscopy: exploring the subcellular topography and speciation of transition metals. Cur Opin Chem Biol. 2007;11:121–127. doi: 10.1016/j.cbpa.2007.02.039. [DOI] [PubMed] [Google Scholar]
  • 38.Deng B, Yang Q, Du G, Tong Y, Xie H, Xiao T. The progress of X-ray fluorescence computed tomography at SSRF. Nucl Instrum Meth B. 2013;305:5–8. [Google Scholar]
  • 39.Nakano K, Tsuji K. Development of laboratory confocal 3D-XRF spectrometer and nondestructive depth profiling. J Anal At Spectrom. 2010;25:562–569. [Google Scholar]
  • 40.Dehlinger M, Fauquet C, Lavandier S, Aumporn O, Jandard F, Arkadiev V, Bjeoumikhov A, Tonneau D. Spatial resolution of confocal XRF technique using capillary optics. Nanoscale Res Lett. 2013;8:271. doi: 10.1186/1556-276X-8-271. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Sakurai K. Total-reflection X-ray fluorescence imaging. Spectrochim Acta B. 1999;54:1497–1503. [Google Scholar]
  • 42.Geil EC, LeBlanc SA, Dale DS, Thorne RE. Application of X-ray fluorescence imaging to ceramics from the American Southwest. J Archaeolog Sci. 2013;40:4780–4784. [Google Scholar]
  • 43.Ortega R, Devès G, Carmona A. Bio-metals imaging and speciation in cells using proton and synchrotron radiation X-ray microspectroscopy. J R Soc Interface. 2009;15:S649–658. doi: 10.1098/rsif.2009.0166.focus. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Ortega R, Cloetens P, Devès G, Carmona A, Bohic S. Iron storage within dopamine neurovesicles revealed by chemical nano-imaging. PLoS One. 2007;2:e925. doi: 10.1371/journal.pone.0000925. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Vine DJ, Pelliccia D, Holzner C, Baines SB, Berry A, McNulty I, Vogt S, Peele AG, Nugent KA. Simultaneous X-ray fluorescence and ptychographic microscopy of cyclotella meneghiniana. Opt Exp. 2012;20:18287–18296. doi: 10.1364/OE.20.018287. [DOI] [PubMed] [Google Scholar]
  • 46.Cotte M, Welcomme E, Solé VA, Salomé M, Menu M, Walter P, Susini J. Synchrotron-based X-ray spectromicroscopy used for the study of an atypical micrometric pigment in 16th century paintings. Anal Chem. 2007;79:6988–6994. doi: 10.1021/ac0708386. [DOI] [PubMed] [Google Scholar]
  • 47.Somogyi A, Drakopoulos M, Vincze L, Vekemans B, Camerani C, Janssens K, Snigirev A, Adams F. ID18F: a new micro-x-ray fluorescence end-station at the European Synchrotron Radiation Facility (ESRF): preliminary results. X-Ray Spectrom. 2001;30:242–252. [Google Scholar]
  • 48.Qiu J, Deng B, Yang Q, Yan F, Li A, Yu X. Internal elemental imaging by scanning X-ray fluorescence microtomography at the hard X-ray microprobe beamline of the SSRF: preliminary experimental results. Nucl Instrum Meth B. 2011;269:2662–2666. [Google Scholar]
  • 49.Di Fabrizio E, Romanato F, Gentili M, Cabrini S, Kaulich B, Susini J, Barrett R. High-efficiency multilevel zone plates for keV X-rays. Nature. 1999;401:895–898. [Google Scholar]
  • 50.Lombi E, de Jonge MD, Donner E, Ryan CG, Paterson D. Trends in hard X-ray fluorescence mapping: environmental applications in the age of fast detectors. Anal Bioanal Chem. 2011;400:1637–1644. doi: 10.1007/s00216-011-4829-2. [DOI] [PubMed] [Google Scholar]
  • 51.Kim SA, Punshon T, Lanzirotti A, Li L, Alonso JM, Ecker JR, Kaplan J, Guerinot ML. Localization of iron in arabidopsis seed requires the vacuolar membrane transporter VIT1. Science. 2006;314:1295–1298. doi: 10.1126/science.1132563. [DOI] [PubMed] [Google Scholar]
  • 52.Patrick JL. Approximate analytic reconstruction in x-ray fluorescence computed tomography. Phys Med Biol. 2004;49:2391–405. doi: 10.1088/0031-9155/49/11/019. [DOI] [PubMed] [Google Scholar]
  • 53.Eduardo XM, De Pierro AR. Exact analytic reconstruction in x-ray fluorescence CT and approximated versions. Phys Med Biol. 2010;55:1007–24. doi: 10.1088/0031-9155/55/4/007. [DOI] [PubMed] [Google Scholar]
  • 54.Bleuet P, Welcomme E, Dooryhee E, Susini J, Hodeau JL, Walter P. Probing the structure of heterogeneous diluted materials by diffraction tomography. Nat Mater. 2008;7:468–472. doi: 10.1038/nmat2168. [DOI] [PubMed] [Google Scholar]
  • 55.Sarret G, Smits EAHP, Michel HC, Isaure MP, Zhao FJ, Tappero R. Chapter one-use of synchrotron-based techniques to elucidate metal uptake and metabolism in plants. In: Donald LS, editor. Adv Agron. Academic Press; 2013. pp. 1–82. [Google Scholar]
  • 56.Pereira GR, Anjos MJ, Rocha HS, Faria P, Pérez CA, Lopes RT. Computed tomography and X-ray fluorescence CT of biological samples. Nucl Instrum Meth A. 2007;580:951–954. [Google Scholar]
  • 57.de Jonge MD, Vogt S. Hard X-ray fluorescence tomography-an emerging tool for structural visualization. Cur Opin Struct Biol. 2010;20:606–614. doi: 10.1016/j.sbi.2010.09.002. [DOI] [PubMed] [Google Scholar]
  • 58.Sutton SR, Bertsch PM, Newville M, Rivers M, Lanzirotti A, Eng P. Microfluorescence and microtomography analyses of heterogeneous earth and environmental materials. Rev Mineral Geochem. 2002;49:429–483. [Google Scholar]
  • 59.de Jonge MD, Holzner C, Baines SB, Twining BS, Ignatyev K, Diaz J, Howard DL, Legnini D, Miceli A, McNulty I, Jacobsen CJ, Vogt S. Quantitative 3D elemental microtomography of cyclotella meneghiniana at 400-nm resolution. Proc Natl Acad Sci U S A. 2010;107:15676–15680. doi: 10.1073/pnas.1001469107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Bower JJ, Leonard SS, Shi X. Conference overview: molecular mechanisms of metal toxicity and carcinogenesis. Mol Cell Biochem. 2005;279:3–15. doi: 10.1007/s11010-005-8210-7. [DOI] [PubMed] [Google Scholar]
  • 61.Flora S. Metal poisoning: threat and management. Al Ameen J Med Sci. 2009;2:4–26. [Google Scholar]
  • 62.Rafati-Rahimzadeh M, Rafati-Rahimzadeh M, Kazemi S, Moghadamnia A. Current approaches of the management of mercury poisoning: need of the hour. DARU. 2014;22:46. doi: 10.1186/2008-2231-22-46. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Tchounwou PB, Yedjou CG, Patlolla AK, Sutton DJ. Heavy metal toxicity and the environment. Exs. 2012;101:133–164. doi: 10.1007/978-3-7643-8340-4_6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Shen S, Li XF, Cullen WR, Weinfeld M, Le XC. Arsenic binding to proteins. Chem Rev. 2013;113:7769–7792. doi: 10.1021/cr300015c. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Munro KL, Mariana A, Klavins AI, Foster AJ, Lai B, Vogt S, Cai Z, Harris HH, Dillon CT. Microprobe XRF mapping and XAS investigations of the intracellular metabolism of arsenic for understanding arsenic-induced toxicity. Chem Res Toxicol. 2008;21:1760–1769. doi: 10.1021/tx800128d. [DOI] [PubMed] [Google Scholar]
  • 66.Andrahennadi R, Pickering IJ. Arsenic accumulation, biotransformation and localisation in bertha armyworm moths. Envir Chem. 2008;5:413–419. [Google Scholar]
  • 67.Rubio M, Perez RD, Perez CA, Eynard AH, Bongiovanni GA. Synchrotron microscopic X-ray fluorescence analysis of the effects of chronic arsenic exposure in rat brain. Radiat Phys Chem. 2008;77:1–8. [Google Scholar]
  • 68.Burns FJ, Rossman T, Vega K, Uddin A, Vogt S, Lai B, Reeder RJ. Mechanism of selenium-induced inhibition of arsenic-enhanced UVR carcinogenesis in mice. Environ Health Persp. 2008;116:703–708. doi: 10.1289/ehp.10978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Kempson IM, Henry DA. Determination of arsenic poisoning and metabolism in hair by synchrotron radiation: the case of Phar Lap. Angew Chem Int Ed. 2010;49:4237–4240. doi: 10.1002/anie.200906594. [DOI] [PubMed] [Google Scholar]
  • 70.Cui G, Ye Z, Zhang R, Wang G, Yuan J. Design and synthesis of a terbium(III) complex-based luminescence probe for time-gated luminescence detection of mercury(II) Ions. J Fluoresc. 2012;22:261–267. doi: 10.1007/s10895-011-0956-6. [DOI] [PubMed] [Google Scholar]
  • 71.Zahir F, Rizwi SJ, Haq SK, Khan RH. Low dose mercury toxicity and human health. Environ Toxicol Pharmacol. 2005;20:351–360. doi: 10.1016/j.etap.2005.03.007. [DOI] [PubMed] [Google Scholar]
  • 72.Korbas M, Blechinger SR, Krone PH, Pickering IJ, George GN. Localizing organomercury uptake and accumulation in zebrafish larvae at the tissue and cellular level. Proc Natl Acad Sci U S A. 2008;105:12108–12112. doi: 10.1073/pnas.0803147105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Korbas M, Krone PH, Pickering IJ, George GN. Dynamic accumulation and redistribution of methylmercury in the lens of developing zebrafish embryos and larvae. J Biol Inorg Chem. 2010;15:1137–1145. doi: 10.1007/s00775-010-0674-6. [DOI] [PubMed] [Google Scholar]
  • 74.Korbas M, MacDonald TC, Pickering IJ, George GN, Krone PH. Chemical form matters: differential accumulation of mercury following inorganic and organic mercury exposures in Zebrafish larvae. ACS Chem Biol. 2012;7:411–420. doi: 10.1021/cb200287c. [DOI] [PubMed] [Google Scholar]
  • 75.Korbas M, Lai B, Vogt S, Gleber SC, Karunakaran C, Pickering IJ, Krone PH, George GN. Methylmercury targets photoreceptor outer segments. ACS Chem Biol. 2013;8:2256–2263. doi: 10.1021/cb4004805. [DOI] [PubMed] [Google Scholar]
  • 76.MacDonald TC, Nehzati S, Sylvain NJ, James AK, Korbas M, Caine S, Pickering IJ, George GN, Krone PH. Phenylthiourea alters toxicity of mercury compounds in zebrafish larvae. J Inorg Biochem. 2015;151:10–17. doi: 10.1016/j.jinorgbio.2015.07.003. [DOI] [PubMed] [Google Scholar]
  • 77.Choudhury S, Thomas JK, Sylvain NJ, Ponomarenko O, Gordon RA, Heald SM, Janz DM, Krone PH, Coulthard I, George GN, Pickering IJ. Selenium preferentially accumulates in the eye lens following embryonic exposure: a confocal X-ray fluorescence imaging study. Environ Sci Technol. 2015;49:2255–2261. doi: 10.1021/es503848s. [DOI] [PubMed] [Google Scholar]
  • 78.Korbas M, O’Donoghue JL, Watson GE, Pickering IJ, Singh SP, Myers GJ, Clarkson TW, George GN. The chemical nature of mercury in human brain following poisoning or environmental exposure. ACS Chem Neurosci. 2010;1:810–818. doi: 10.1021/cn1000765. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79.MacDonald TC, Korbas M, James AK, Sylvain NJ, Hackett MJ, Nehzati S, Krone PH, George GN, Pickering IJ. Interaction of mercury and selenium in the larval stage zebrafish vertebrate model. Metallomics. 2015;7:1247–1255. doi: 10.1039/c5mt00145e. [DOI] [PubMed] [Google Scholar]
  • 80.Harris HH, Vogt S, Eastgate H, Legnini DG, Hornberger B, Cai Z, Lai B, Lay PA. Migration of mercury from dental amalgam through human teeth. J Synchrotron Radiat. 2008;15:123–128. doi: 10.1107/S0909049507061468. [DOI] [PubMed] [Google Scholar]
  • 81.Swanston T, Varney T, Coulthard I, George GN, Pickering IJ, Murphy R, Cooper DM. Synchrotron X-ray fluorescence imaging evidence of biogenic mercury identified in a burial in colonial Antigua. J Archaeol Sci. 2015;58:26–30. [Google Scholar]
  • 82.Wittmers LE, Wallgren J, Alich A, Aufderheide AC, Rapp G. Lead in Bone. IV. distribution of lead in the human skeleton. Arch Environ Health. 1988;43:381–391. doi: 10.1080/00039896.1988.9935855. [DOI] [PubMed] [Google Scholar]
  • 83.Zoeger N, Roschger P, Hofstaetter JG, Jokubonis C, Pepponi G, Falkenberg G, Fratzl P, Berzlanovich A, Osterode W, Streli C, Wobrauschek P. Lead accumulation in tidemark of articular cartilage. Osteoarthr Cartil. 2006;14:906–913. doi: 10.1016/j.joca.2006.03.001. [DOI] [PubMed] [Google Scholar]
  • 84.Roschger A, Hofstaetter JG, Pemmer B, Zoeger N, Wobrauschek P, Falkenberg G, Simon R, Berzlanovich A, Thaler HW, Roschger P, Klaushofer K, Streli C. Differential accumulation of lead and zinc in double-tidemarks of articular cartilage. Osteoarthr Cartil. 2013;21:1707–1715. doi: 10.1016/j.joca.2013.06.029. [DOI] [PubMed] [Google Scholar]
  • 85.Zoeger N, Streli C, Wobrauschek P, Jokubonis C, Pepponi G, Roschger P, Hofstaetter J, Berzlanovich A, Wegrzynek D, Chinea-Cano E, Markowicz A, Simon R, Falkenberg G. Determination of the elemental distribution in human joint bones by SR micro XRF. X-Ray Spectrom. 2008;37:3–11. [Google Scholar]
  • 86.Pemmer B, Roschger A, Wastl A, Hofstaetter JG, Wobrauschek P, Simon R, Thaler HW, Roschger P, Klaushofer K, Streli C. Spatial distribution of the trace elements zinc, strontium and lead in human bone tissue. Bone. 2013;57:184–193. doi: 10.1016/j.bone.2013.07.038. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 87.Zoeger N, Wobrauschek P, Streli C, Pepponi G, Roschger P, Falkenberg G, Osterode W. Distribution of Pb and Zn in slices of human bone by synchrotron μ-XRF. X-Ray Spectrom. 2005;34:140–143. [Google Scholar]
  • 88.Bellis DJ, Li D, Chen Z, Gibson WM, Parsons PJ. Measurement of the microdistribution of strontium and lead in bone via benchtop monochromatic microbeam X-ray fluorescence with a low power source. J Anal Atom Spectrom. 2009;24:622–626. doi: 10.1039/B820067J. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 89.Arora M, Kennedy BJ, Ryan CG, Boadle RA, Walker DM, Harland CL, Lai B, Cai Z, Vogt S, Zoellner H, Chan SW. The application of synchrotron radiation induced X-ray emission in the measurement of zinc and lead in Wistar rat ameloblasts. Arch Oral Biol. 2007;52:938–944. doi: 10.1016/j.archoralbio.2007.04.003. [DOI] [PubMed] [Google Scholar]
  • 90.Lanzirotti A, Bianucci R, LeGeros R, Bromage TG, Giuffra V, Ferroglio E, Fornaciari G, Appenzeller O. Assessing heavy metal exposure in Renaissance Europe using synchrotron microbeam techniques. J Archaeol Sci. 2014;52:204–217. [Google Scholar]
  • 91.Lison D, De Boeck M, Verougstraete V, Kirsch-Volders M. Update on the genotoxicity and carcinogenicity of cobalt compounds. Occup Environ Med. 2001;58:619–625. doi: 10.1136/oem.58.10.619. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 92.Leonardo T, Farhi E, Boisson AM, Vial J, Cloetens P, Bohic S, Rivasseau C. Determination of elemental distribution in green micro-algae using synchrotron radiation nano X-ray fluorescence (SR-nXRF) and electron microscopy techniques - subcellular localization and quantitative imaging of silver and cobalt uptake by coccomyxa actinabiotis. Metallomics. 2014;6:316–329. doi: 10.1039/c3mt00281k. [DOI] [PubMed] [Google Scholar]
  • 93.Ortega R, Bresson C, Fraysse A, Sandre C, Devès G, Gombert C, Tabarant M, Bleuet P, Seznec H, Simionovici A, Moretto P, Moulin C. Cobalt distribution in keratinocyte cells indicates nuclear and perinuclear accumulation and interaction with magnesium and zinc homeostasis. Toxicol Lett. 2009;188:26–32. doi: 10.1016/j.toxlet.2009.02.024. [DOI] [PubMed] [Google Scholar]
  • 94.Zhitkovich A. Chromium in drinking water: sources, metabolism, and cancer risks. Chem Res Toxicol. 2011;24:1617–1629. doi: 10.1021/tx200251t. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 95.Kemner KM, Kelly SD, Lai B, Maser J, O’Loughlin EJ, Sholto-Douglas D, Cai Z, Schneegurt MA, Kulpa CF, Nealson KH. Elemental and redox analysis of single bacterial cells by X-ray microbeam analysis. Science. 2004;306:686–687. doi: 10.1126/science.1103524. [DOI] [PubMed] [Google Scholar]
  • 96.Ortega R, Fayard B, Salomé M, Devès G, Susini J. Chromium oxidation state mapping in human cells. J Phys IV France. 2003;104:289–292. [Google Scholar]
  • 97.Ortega R, Fayard B, Salomé M, Devès G, Susini J. Chromium oxidation state imaging in mammalian cells exposed in vitro to soluble or particulate chromate compounds. Chem Res Toxicol. 2005;18:1512–1519. doi: 10.1021/tx049735y. [DOI] [PubMed] [Google Scholar]
  • 98.Dillon C, Lay P, Kennedy B, Stampfl A, Cai Z, Ilinski P, Rodrigues W, Legnini D, Lai B, Maser J. Hard X-ray microprobe studies of chromium(VI)-treated V79 Chinese hamster lung cells: intracellular mapping of the biotransformation products of a chromium carcinogen. J Biol Inorg Chem. 2002;7:640–645. doi: 10.1007/s00775-002-0343-5. [DOI] [PubMed] [Google Scholar]
  • 99.Harris H, Levina A, Dillon C, Mulyani I, Lai B, Cai Z, Lay P. Time-dependent uptake, distribution and biotransformation of chromium(VI) in individual and bulk human lung cells: application of synchrotron radiation techniques. J Biol Inorg Chem. 2005;10:105–118. doi: 10.1007/s00775-004-0617-1. [DOI] [PubMed] [Google Scholar]
  • 100.Durham T, Snow E. Cancer: cell structures, carcinogens and genomic instability. Birkhäuser Basel; 2006. Metal ions and carcinogenesis; pp. 97–130. [Google Scholar]
  • 101.Tokar EJ, Benbrahim-Tallaa L, Waalkes MP. Metal ions in human cancer development. Met Ions Life Sci. 2011;8:375–401. [PubMed] [Google Scholar]
  • 102.Smith AJ, Dieppe P, Porter M, Blom AW. Risk of cancer in first seven years after metal-on-metal hip replacement compared with other bearings and general population: linkage study between the national joint registry of England and Wales and hospital episode statistics. BMJ. 2012;344:e2383. doi: 10.1136/bmj.e2383. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 103.Rocha HS, Pereira GR, Anjos MJ, Faria P, Kellermann G, Pérez CA, Tirao G, Mazzaro I, Giles C, Lopes RT. Diffraction enhanced imaging and x-ray fluorescence microtomography for analyzing biological samples. X-Ray Spectrom. 2007;36:247–253. [Google Scholar]
  • 104.Pereira GR, Rocha HS, Anjos MJ, Faria P, Pérez CA, Lopes RT. X-ray fluorescence and X-ray transmission microtomography imaging system. Nucl Instr Meth Phys Res A. 2007;581:128–132. [Google Scholar]
  • 105.Ortega R, Deves G, Carmona A. Bio-metals imaging and speciation in cells using proton and synchrotron radiation X-ray microspectroscopy. J R Soc Interface. 2009;6(Suppl 5):S649–658. doi: 10.1098/rsif.2009.0166.focus. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 106.Farquharson MJ, Geraki K. The use of combined trace element XRF and EDXRD data as a histopathology tool using a multivariate analysis approach in characterizing breast tissue. X-Ray Spectrom. 2004;33:240–245. [Google Scholar]
  • 107.Masami A, Katsuhito Y, Chiho O, Hiroyasu E, Kazuyuki H, Hiroshi S, Gang L, Anton M, Toshiaki K. Attempt at two-dimensional mapping of X-ray fluorescence from breast cancer tissue. Jpn J Appl Phy. 2005;44:L998. [Google Scholar]
  • 108.Geraki K, Farquharson MJ, Bradley DA. Concentrations of Fe, Cu and Zn in breast tissue: a synchrotron XRF study. Phys Med Biol. 2002;47:2327–2339. doi: 10.1088/0031-9155/47/13/310. [DOI] [PubMed] [Google Scholar]
  • 109.Farquharson MJ, Geraki K, Falkenberg G, Leek R, Harris A. The localisation and micro-mapping of copper and other trace elements in breast tumours using a synchrotron micro-XRF system. Appl Radiat Isot. 2007;65:183–188. doi: 10.1016/j.apradiso.2006.08.013. [DOI] [PubMed] [Google Scholar]
  • 110.Pereira GR, Rocha HS, Anjos MJ, Farias PC, Perez CA, Lopes RT. Elemental distribution mapping on breast tissue samples. Eur J Radiol. 2008;68:S104–108. doi: 10.1016/j.ejrad.2008.04.047. [DOI] [PubMed] [Google Scholar]
  • 111.Farquharson MJ, Al-Ebraheem A, Falkenberg G, Leek R, Harris AL, Bradley DA. The distribution of trace elements Ca, Fe, Cu and Zn and the determination of copper oxidation state in breast tumour tissue using muSRXRF and muXANES. Phys Med Biol. 2008;53:3023–3037. doi: 10.1088/0031-9155/53/11/018. [DOI] [PubMed] [Google Scholar]
  • 112.Podgórczyk M, Kwiatek WM, Grolimund D, Borca C. Technical aspects of Zn microanalysis of human prostate cancer tissues and cells. Radiation Physics and Chemistry. 2009;78:S53–S57. [Google Scholar]
  • 113.Ide-Ektessabi A, Fujisawa S, Sugimura K, Kitamura Y, Gotoh A. Quantitative analysis of zinc in prostate cancer tissues using synchrotron radiation microbeams. X-Ray Spectrom. 2002;31:7–11. [Google Scholar]
  • 114.Leitao RG, Santos CAN, Palumbo A, Souza PAVR, Pereira GR, Anjos MJ, Nasciutti LE, Lopes RT. Distribution of Fe, Cu and Zn in Cellular spheroid derived human prostate tumor cells by synchrotron X-Ray fluorescence. IEEE Trans Nucl Sci. 2013;60:758–762. [Google Scholar]
  • 115.Al-Ebraheem A, Mersov A, Gurusamy K, Farquharson MJ. Distribution of Ca, Fe, Cu and Zn in primary colorectal cancer and secondary colorectal liver metastases. Nucl Instr Meth Phys Res A. 2010;619:338–343. [Google Scholar]
  • 116.Al-Ebraheem A, Farquharson MJ, Ryan E. The evaluation of biologically important trace metals in liver, kidney and breast tissue. Appl Radiat Isot. 2009;67:470–474. doi: 10.1016/j.apradiso.2008.06.018. [DOI] [PubMed] [Google Scholar]
  • 117.Finney L, Vogt S, Fukai T, Glesne D. Copper and angiogenesis: unravelling a relationship key to cancer progression. Clin Exp Pharmacol Physiol. 2009;36:88–94. doi: 10.1111/j.1440-1681.2008.04969.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 118.Finney L, Mandava S, Ursos L, Zhang W, Rodi D, Vogt S, Legnini D, Maser J, Ikpatt F, Olopade OI, Glesne D. X-ray fluorescence microscopy reveals large-scale relocalization and extracellular translocation of cellular copper during angiogenesis. Proc Natl Acad Sci U S A. 2007;104:2247–2252. doi: 10.1073/pnas.0607238104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 119.Collingwood JF, Davidson MR. The role of iron in neurodegenerative disorders: insights and opportunities with synchrotron light. Front Pharmacol. 2014;5:191–210. doi: 10.3389/fphar.2014.00191. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 120.Vogt S, Ralle M. Opportunities in mul tidimensional trace metal imaging: taking copper-associated disease research to the next level. Anal Bioanal Chem. 2013;405:1809–1820. doi: 10.1007/s00216-012-6437-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 121.Bourassa MW, Miller LM. Metal imaging in neurodegenerative diseases. Metallomics. 2012;4:721–738. doi: 10.1039/c2mt20052j. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 122.Popescu BF, Nichol H. Mapping brain metals to evaluate therapies for neurodegenerative disease. CNS Neurosci Ther. 2011;17:256–268. doi: 10.1111/j.1755-5949.2010.00149.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 123.Pushie MJ, Pickering IJ, Martin GR, Tsutsui S, Jirik FR, George GN. Prion protein expression level alters regional copper, iron and zinc content in the mouse brain. Metallomics. 2011;3:206–214. doi: 10.1039/c0mt00037j. [DOI] [PubMed] [Google Scholar]
  • 124.Grubman A, James SA, James J, Duncan C, Volitakis I, Hickey JL, Crouch PJ, Donnelly PS, Kanninen KM, Liddell JR, Cotman SL, de Jonge MD, White AR. X-ray fluorescence imaging reveals subcellular biometal disturbances in a childhood neurodegenerative disorder. Chem Sci. 2014;5:2503–2516. doi: 10.1039/C4SC00316K. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 125.Daoust A, Barbier EL, Bohic S. Manganese enhanced MRI in rat hippocampus: a correlative study with synchrotron X-ray microprobe. NeuroImage. 2013;64:10–18. doi: 10.1016/j.neuroimage.2012.09.025. [DOI] [PubMed] [Google Scholar]
  • 126.Robison G, Sullivan B, Cannon JR, Pushkar Y. Identification of dopaminergic neurons of the substantia nigra pars compacta as a target of manganese accumulation. Metallomics. 2015;7:748–755. doi: 10.1039/c5mt00023h. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 127.Robison G, Zakharova T, Fu S, Jiang W, Fulper R, Barrea R, Zheng W, Pushkar Y. X-ray fluorescence imaging of the hippocampal formation after manganese exposure. Metallomics. 2013;5:1554–1565. doi: 10.1039/c3mt00133d. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 128.Silasi G, Klahr AC, Hackett MJ, Auriat AM, Nichol H, Colbourne F. Prolonged therapeutic hypothermia does not adversely impact neuroplasticity after global ischemia in rats. J Cereb Blood Flow Metab. 2012;32:1525–1534. doi: 10.1038/jcbfm.2012.38. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 129.Chwiej J, Dulinska J, Janeczko K, Appel K, Setkowicz Z. Variations in elemental compositions of rat hippocampal formation between acute and latent phases of pilocarpine-induced epilepsy: an X-ray fluorescence microscopy study. J Biol Inorg Chem. 2012;17:731–739. doi: 10.1007/s00775-012-0892-1. [DOI] [PubMed] [Google Scholar]
  • 130.Chwiej J, Sarapata A, Janeczko K, Stegowski Z, Appel K, Setkowicz Z. X-ray fluorescence analysis of long-term changes in the levels and distributions of trace elements in the rat brain following mechanical injury. J Biol Inorg Chem. 2011;16:275–283. doi: 10.1007/s00775-010-0724-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 131.Chwiej J, Kutorasinska J, Janeczko K, Gzielo-Jurek K, Uram L, Appel K, Simon R, Setkowicz Z. Progress of elemental anomalies of hippocampal formation in the pilocarpine model of temporal lobe epilepsy--an X-ray fluorescence microscopy study. Anal Bioanal Chem. 2012;404:3071–3080. doi: 10.1007/s00216-012-6425-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 132.Chwiej J, Winiarski W, Ciarach M, Janeczko K, Lankosz M, Rickers K, Setkowicz Z. The role of trace elements in the pathogenesis and progress of pilocarpine-induced epileptic seizures. J Biol Inorg Chem. 2008;13:1267–1274. doi: 10.1007/s00775-008-0411-6. [DOI] [PubMed] [Google Scholar]
  • 133.Kumar A, Singh A, Ekavali A review on Alzheimer’s disease pathophysiology and its management: an update. Pharmacol Rep. 2015;67:195–203. doi: 10.1016/j.pharep.2014.09.004. [DOI] [PubMed] [Google Scholar]
  • 134.Huang Y, Mucke L. Alzheimer mechanisms and therapeutic strategies. Cell. 2012;148:1204–1222. doi: 10.1016/j.cell.2012.02.040. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 135.Braidy N, Poljak A, Marjo C, Rutlidge H, Rich A, Jayasena T, Inestrosa NC, Sachdev P. Metal and complementary molecular bioimaging in Alzheimer’s disease. Front Aging Neurosc. 2014;6:138. doi: 10.3389/fnagi.2014.00138. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 136.Wang HJ, Wang M, Wang B, Meng XY, Wang Y, Li M, Feng WY, Zhao YL, Chai ZF. Quantitative imaging of element spatial distribution in the brain section of a mouse model of Alzheimer’s disease using synchrotron radiation X-ray fluorescence analysis. J Anal Atomic Spectrom. 2010;25:328–333. [Google Scholar]
  • 137.Leskovjan AC, Lanzirotti A, Miller LM. Amyloid plaques in PSAPP mice bind less metal than plaques in human Alzheimer’s disease. NeuroImage. 2009;47:1215–1220. doi: 10.1016/j.neuroimage.2009.05.063. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 138.Leskovjan AC, Kretlow A, Lanzirotti A, Barrea R, Vogt S, Miller LM. Increased brain iron coincides with early plaque formation in a mouse model of Alzheimer’s disease. NeuroImage. 2011;55:32–38. doi: 10.1016/j.neuroimage.2010.11.073. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 139.Wang H, Wang M, Wang B, Li M, Chen H, Yu X, Zhao Y, Feng W, Chai Z. The distribution profile and oxidation states of biometals in APP transgenic mouse brain: dyshomeostasis with age and as a function of the development of Alzheimer’s disease. Metallomics. 2012;4:289–296. doi: 10.1039/c2mt00104g. [DOI] [PubMed] [Google Scholar]
  • 140.Adlard PA, Parncutt J, Lal V, James S, Hare D, Doble P, Finkelstein DI, Bush AI. Metal chaperones prevent zinc-mediated cognitive decline. Neurobiol Dis. 2015;81:196–202. doi: 10.1016/j.nbd.2014.12.012. [DOI] [PubMed] [Google Scholar]
  • 141.Politis M. Neuroimaging in Parkinson disease: from research setting to clinical practice. Nat Rev Neurol. 2014;10:708–722. doi: 10.1038/nrneurol.2014.205. [DOI] [PubMed] [Google Scholar]
  • 142.Connolly BS, Lang AE. Pharmacological treatment of parkinson disease: a review. JAMA. 2014;311:1670–1683. doi: 10.1001/jama.2014.3654. [DOI] [PubMed] [Google Scholar]
  • 143.Davie CA. A review of Parkinson’s disease. Br Med Bull. 2008;86:109–127. doi: 10.1093/bmb/ldn013. [DOI] [PubMed] [Google Scholar]
  • 144.Bogdan FG, Martin JG, Uwe B, Alex VG, Michael EK, Richard PE, Katharina L, Richard MD, Graham NG, Akela DH, Sheri MH, Chapman LD, Ingrid JP, Helen N. Mapping metals in Parkinson’s and normal brain using rapid-scanning x-ray fluorescence. Phys Med Biol. 2009;54:651. doi: 10.1088/0031-9155/54/3/012. [DOI] [PubMed] [Google Scholar]
  • 145.Chwiej J. The use of cluster and discriminant analysis in the investigations of the role of trace metals in the pathogenesis of Parkinson’s disease. J Trace Elem Med Biol. 2010;24:78–88. doi: 10.1016/j.jtemb.2009.11.002. [DOI] [PubMed] [Google Scholar]
  • 146.Davies KM, Bohic S, Carmona A, Ortega R, Cottam V, Hare DJ, Finberg JP, Reyes S, Halliday GM, Mercer JF, Double KL. Copper pathology in vulnerable brain regions in Parkinson’s disease. Neurobiol Aging. 2014;35:858–866. doi: 10.1016/j.neurobiolaging.2013.09.034. [DOI] [PubMed] [Google Scholar]
  • 147.Robison G, Zakharova T, Fu S, Jiang W, Fulper R, Barrea R, Marcus MA, Zheng W, Pushkar Y. X-Ray fluorescence imaging: a new tool for studying manganese neurotoxicity. PLoS One. 2012;7:e48899. doi: 10.1371/journal.pone.0048899. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 148.Dučić T, Barski E, Salome M, Koch JC, Bähr M, Lingor P. X-ray fluorescence analysis of iron and manganese distribution in primary dopaminergic neurons. J Neurochem. 2013;124:250–261. doi: 10.1111/jnc.12073. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 149.Carmona A, Devès G, Roudeau S, Cloetens P, Bohic S, Ortega R. Manganese accumulates within golgi apparatus in dopaminergic cells as revealed by synchrotron X-ray fluorescence nanoimaging. ACS Chem Neurosci. 2010;1:194–203. doi: 10.1021/cn900021z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 150.Jung C, Kaul MG, Bruns OT, Ducic T, Freund B, Heine M, Reimer R, Meents A, Salmen SC, Weller H, Nielsen P, Adam G, Heeren J, Ittrich H. Intraperitoneal injection improves the uptake of nanoparticle-labeled high-density lipoprotein to atherosclerotic plaques compared with intravenous injection: a multimodal imaging study in ApoE knockout mice. Circ Cardiovasc Imaging. 2014;7:303–311. doi: 10.1161/CIRCIMAGING.113.000607. [DOI] [PubMed] [Google Scholar]
  • 151.House MJ, Fleming AJ, de Jonge MD, Paterson D, Howard DL, Carpenter JP, Pennell DJ, St Pierre TG. Mapping iron in human heart tissue with synchrotron x-ray fluorescence microscopy and cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2014;16:80. doi: 10.1186/s12968-014-0080-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 152.Witting PK, Harris HH, Rayner BS, Aitken JB, Dillon CT, Stocker R, Lai B, Cai Z, Lay PA. The endothelium-derived hyperpolarizing factor, H2O2, promotes metal-ion efflux in aortic endothelial cells: elemental mapping by a hard X-ray microprobe. Biochem. 2006;45:12500–12509. doi: 10.1021/bi0604375. [DOI] [PubMed] [Google Scholar]
  • 153.Silva ALM, Figueroa R, Jaramillo A, Carvalho ML, Veloso JF. Performance of a gaseous detector based energy dispersive X-ray fluorescence imaging system: analysis of human teeth treated with dental amalgam. Spectrochim Acta B. 2013;86:115–122. [Google Scholar]
  • 154.Harris H, Vogt S, Eastgate H, Lay P. A link between copper and dental caries in human teeth identified by X-ray fluorescence elemental mapping. J BiolInorg Chem. 2008;13:303–306. doi: 10.1007/s00775-007-0321-z. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Nuclear Medicine and Molecular Imaging are provided here courtesy of e-Century Publishing Corporation

RESOURCES